XTL Biopharmaceuticals Ltd.

convening of meeting false


�� "�	2 670
X T L BIOPHARMACEUTICALS LTD
Corporation no: 520039470	4313
- - -


	Israel Securities Authority			Tel Aviv Stock Exchange		C460 ( Public )		Reported via MAGNA:	22/06/2017
	www.isa.gov.il			www.tase.co.il				Reference:	2017-02-064227	Time of broadcast: 15:54 15:20:26

Immediate Report of MeetingWhether to enable voting via the Voting System YesExplanation: This form is to be used only by companies which are subject to the Israeli Companies Law 5759-1999

The corporation hereby gives notice of: convening of meeting

The reference number for the most recent notification of a meeting is _________ which was called for the date _________


Reason for Postponement or Cancellation: _________	_________

Explanation: Please refer to the reference number of the most recent notification of the convening or deferral of the meeting

1. On the date: 14/06/2017it was decided on convening of meeting annual meeting _________ ,that will be held on the day Thursday on the date : 27/07/2017 time: 11:00


at address:	7 Metsada St., B.S.R Tower 4, 33 Floor, Bnei Brak, Israel.

2. Details of security in the Stock Exchange that entitles the holder thereof to participate in the meetingSecurity number 1085497Security name �� "� 0.1 �"�Security type ShareExplanation: If a meeting concerning more than one security is required, a report on C460 will be made separately for every additional security. Reports that specify additional security numbers must be followed by an amending reportThe determining date for entitlement to participate and vote in the meeting: 27/06/2017

3. On the Agenda - Items/Decisions to be raised at the meeting11The item/decision and its particulars:To approve the re-appointment of Kesselman & Kesselman, Israel CPAs, a member firm of PricewaterhouseCoopers International Limited, as our independent registered public accounting firm for the year ending December 31, 2017 and until our next annual general meeting of shareholders, and to authorize our board of directors to fix such accounting firm�s annual compensation.

Enable Editing the item/decision and its particulars

Does this require disclosure of any ties or other features of the voting security holder? No_________Note: Please pose Yes/No questions. The question will appear in the voting system alongside the decision that is on the agenda, and the voter will have the option of voting Yes or No, and may add additional information if the voter votes Yes. For example, this field may be used to add a question pertaining to issues that require a declaration of personal interest and details of the interest if any.

In the event of a meeting of bondholdersResolution pertaining to other interests _________Details of the other interests_________Note: Details of the other interest determine which declaration is included in the online voting system. Please pose Yes/No questions. The question will appear in the voting system alongside the decision that is on the agenda, and the voter will have the option of voting Yes or No, and may add additional information if the voter votes Yes.

Resolution to require holders to provide additional details _________List of additional details required of holders or the manner in which meetings are convened (in the event of a meeting convened under section 350 of the Companies Law 350):_________Note: This field determines which demand for additional details is included in the online voting system. Voters may add text in the field.


	No longer on the agenda